Keeping Track: US FDA Clears Kisqali For Breast Cancer And Keytruda In Lymphoma, But Turns Down AZ's ZS-9 Again
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
The latest drug development news and highlights from our US FDA Performance Tracker.
Original new drugs and biologics recently approved by US FDA.
Deterring intravenous abuse over other routes of abuse should be agency's priority, some advisory committee members say during discussion of abuse patterns and risks with Endo’s reformulated Opana ER.